AgeX Therapeutics, Inc. / Fundamentals

    Income statement

    Net revenue
    €80.26K
    Cost of goods sold
    €57.82K
    Gross profit
    -€34.52K
    SG&A expenses
    €9.63M
    R&D expenses
    €12.54M
    EBITDA
    -€13.97M
    D&A
    -€78.54K
    EBIT
    -€22.05M
    Interest expenses
    -€3.01M
    EBT
    -€2.34M
    Tax expenses
    -€8.20M
    Net income
    -€2.33M

    Cash flow statement

    Net deferred tax
    €1.42M
    Non-cash items
    -€29.15M
    Changes in working capital
    -€1.18M
    Operating cash flow
    -€24.71M
    Capex
    €18.99K
    Other investing cash flow
    -€30.21K
    Net investing cash flow
    -€49.19K
    Total cash dividends paid
    -€970.92K
    Issuance of common stock
    -€27.05M
    Debt repayment
    €0.00
    Other financing cash flow
    €46.67M
    Net financing cash flow
    €17.63M
    Foreign exchange effects
    €0.00
    Net change in cash
    €0.00
    Cash at end of period
    €0.00
    Free cash flow
    -€24.69M

    Balance sheet

    Cash and cash equivalents
    €5.21M
    Cash and short-term investments
    €5.21M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €1.68M
    Total current assets
    €6.90M
    Property, plant & equipment
    €819.88K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €819.88K
    Total assets
    €7.72M
    Accounts payable
    €1.47M
    Short-term debt
    €0.00
    Other current liabilities
    €1.60M
    Total current liabilities
    €3.07M
    Long-term debt
    €159.66K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €3.06M
    Total non-current liabilities
    €3.22M
    Total liabilities
    €6.30M
    Common stock
    €863.04
    Retained earnings
    -€47.97M
    Other equity
    €0.00
    Total equity
    €1.42M
    Total liabilities and shareholders' equity
    €7.72M

    Company information

    Market capitalization
    €23.68M
    Employees
    4
    Enterprise Value
    €57.36M

    Company ratios

    Gross margin
    -43.0%
    EBITDA margin
    -17,403.2%
    EBIT margin
    -27,468.8%
    EBT margin
    -2,911.8%
    Net margin
    -2,901.1%
    ROE
    -163.9%
    ROA
    -30.2%
    Asset turnover
    1.0%
    FCF margin
    -30,814.0%
    FCF yield
    -104.5%
    Efficiency ratio
    17,503.2%
    Net sales per employee
    €20.07K
    Net income per employee
    -€582.12K

    Notifications